Lexeo Therapeutics stock crashed Monday despite promising results for a gene therapy designed to treat heart problems of a genetic condition.

The post Why Top 4% Biotech Stock Lexeo Therapeutics Just Gave Up A Breakout appeared first on Investor’s Business Daily.